GovChime
Notice ID: 2b0e338e8b85489297cc5902ef54f6f0Award NoticeAwarded

Lamotrigine Award

Awarded on May 13, 2025. Full description on SAM.gov.

Awarded tounder SPE2D2-25-D-0013 (source: SAM.gov award notice)• $16.0M

Overview

Posted
April 28, 2026
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Place of performance
Brookhaven, New York, 11719
PSC
6505: DRUGS AND BIOLOGICALS
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
May 13, 2025
Award amount (SAM.gov award notice)
$16.0M

Identifiers

Solicitation number
SPE2D2-25-D-0013
Notice ID
2b0e338e8b85489297cc5902ef54f6f0
Award number (PIID)
SPE2D2-25-D-0013

Description

Modification to exercise Option Year 1 for Lamotrigine ER Tablets is attached. 

Full description on SAM.gov

Award Overview

Award Number

SPE2D2-25-D-0013

Award Amount (SAM.gov award notice)

$16.0M

Award Date

May 13, 2025

Awardee

Awardee UEI

SFPGXE6XPS93

Awardee CAGE Code

4QGW8

Awardee Address

Pulaski, TN 38478, UNITED STATES

Original Solicitation

Notice ID: 2b0e338e8b85489297cc5902ef54f6f0

Posted Date: Apr 28, 2026

Original Response Deadline: Not specified

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (2)

  • Signed - MOD Option YR 1 - Lamotrigine.pdf

    114 KBAdded in Award Notice version 4Posted
    Download
  • Bilaterally Signed Award Doc_01.May.2025.pdf

    8.4 MBAdded in Award Notice version 2Posted
    Download

Lifecycle

  1. 3
    Version 3SolicitationArchived

    Lamotrigine

    Notice 70dd900040174c96aded859a9530f337 on SAM.gov

  2. 2
    Version 2Award Notice

    Type changed from Solicitation to Award Notice

    Lamotrigine Award

    Notice ce83b6170d264557ac2a7dae29b9c443 on SAM.gov

  3. 4
    Version 4Award NoticeCurrent

    Lamotrigine Award

    Notice 2b0e338e8b85489297cc5902ef54f6f0 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

SPE2D2-25-D-0013

Archive Date

May 30, 2030

Office Address

PHILADELPHIA, PA, 19111